Two doses of the vaccine for shingles, Shingrix, are funded for those aged 65 years, but expanding this eligibility would ...

“While it’s important that access to funded Shingrix is available for immunocompromised people, we note that people over 50 years are also at an increased risk of developing shingles. We are ...

As part of the pharma company's ongoing “Thrive@50+” campaign, the 59-year-old Shields has directed a 3-minute film about shingles, featuring herself, other 50+ influencers -- football mom ...

Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein elicits robust humoral and cellular immune responses ...

encouraging adults 50 years of age and older to talk to their doctor or pharmacist about their risk for shingles — a disease that affects about 1 million people annually in the US — and about ...

And it's not as uncommon as you might think — every year, there are about one million cases of shingles in the US alone. Age is the most important risk factor for shingles, so anyone over 50 ...

head-to-head versus Shingrix in participants aged 50 years and older at the ID Week 2024 conference under way in Los Angeles. Amezosvatein met all primary endpoints in the randomized, active ...

2 SHINGRIX is approved for the prevention of shingles (herpes zoster) in adults aged 50 years and older. AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by ...

Shingles is a viral infection that causes a painful, blistering rash.It is caused by the same virus as chickenpox, called the varicella zoster virus. (Getty Images/iStockphoto) Property News: An ...

Between 10-18% of those who get shingles develop post-herpetic neuralgia (PHN), a condition marked by debilitating nerve pain lasting over six months and often beyond one year. There is no ...

William Smith with the Alliance for Multispecialty Research, the primary investigator on this Phase 2 trial and a board-certified physician who has been involved in more than 1,900 clinical trials ...